TY - JOUR T1 - Toilets dominate environmental detection of SARS-CoV-2 virus in a hospital JF - medRxiv DO - 10.1101/2020.04.03.20052175 SP - 2020.04.03.20052175 AU - Zhen Ding AU - Hua Qian AU - Bin Xu AU - Ying Huang AU - Te Miao AU - Hui-Ling Yen AU - Shenglan Xiao AU - Lunbiao Cui AU - Xiaosong Wu AU - Wei Shao AU - Yan Song AU - Li Sha AU - Lian Zhou AU - Yan Xu AU - Baoli Zhu AU - Yuguo Li Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/07/2020.04.03.20052175.abstract N2 - Background Respiratory and faecal aerosols play a suspected role in transmitting the SARS-CoV-2 virus. We performed extensive environmental sampling in a dedicated hospital building for Covid-19 patients in both toilet and non-toilet environments, and analysed the associated environmental factors.Methods We collected data of the Covid-19 patients. 107 surface samples, 46 air samples, two exhaled condensate samples, and two expired air samples were collected were collected within and beyond the four three-bed isolation rooms. We reviewed the environmental design of the building and the cleaning routines. We conducted field measurement of airflow and CO2 concentrations.Findings The 107 surface samples comprised 37 from toilets, 34 from other surfaces in isolation rooms (ventilated at 30-60 L/s), and 36 from other surfaces outside isolation rooms in the hospital. Four of these samples were positive, namely two ward door-handles, one bathroom toilet-seat cover and one bathroom door-handle; and three were weakly positive, namely one bathroom toilet seat, one bathroom washbasin tap lever and one bathroom ceiling-exhaust louvre. One of the 46 air samples was weakly positive, and this was a corridor air sample. The two exhaled condensate samples and the two expired air samples were negative.Interpretation The faecal-derived aerosols in patients’ toilets contained most of the detected SARS-CoV-2 virus in the hospital, highlighting the importance of surface and hand hygiene for intervention.Funding The work were partially supported by the National Natural Science Foundation of China (no 41977370), the Research Grants Council of Hong Kong’s (no 17202719) (no C7025-16G), and Scientific Research Fund of Jiangsu Provincial Department of Health (no S21017002).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work were partially supported by the National Natural Science Foundation of China (no 41977370), the Research Grants Council of Hong Kong’s (no 17202719) (no C7025-16G), and Scientific Research Fund of Jiangsu Provincial Department of Health (no S21017002).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot available except those published ER -